Avid Bioservices Inc (CDMO)

[pphmtoolong]

The CC was very upbeat. Steve and the others clearly see a great future for Peregrine.

I know some will find something to dislike, but I liked the focus on the future of Bavituximab. Management continues to follow a plan to convince the pharma world that Bavi belongs as a major new addition to the cancer treatment arsenal.

Employing MSK as your product's validator is very smart IMO. If MSK gives Bavi their approval, who is going to doubt Bavi's value?

If AstraZeneca starts cozing up to Peregrine, don't you think others will start moving closer as well?

As King and other pointed out, Bavi is an ideal partner. It has proven safe, and it is gradually proving that it makes many other drugs more effective.

If the share price does the usual dip, it will be hard to resist adding.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul